The pipeline of new molecules and regimens against drug-resistant tuberculosis

por Black, Todd A., Buchwald, Ulrike K.
Publicado 2021

Response to Shami et al. ‘Evaluating the cost-effectiveness of a sequential pneumococcal vaccination compared to single dose vaccination strategy for adults in Hong Kong’ (Hum Vacc...

por Buchwald, Ulrike K., Folaranmi, Temitope, Weiss, Thomas
Publicado 2020

Comment on Chandler et al. 23-Valent Pneumococcal Polysaccharide Vaccination Does Not Prevent Community-Acquired Pneumonia Hospitalizations Due to Vaccine-Type Streptococcus pneumo...

por Cossrow, Nicole, Joshi, Rennie, Klinker, Kenneth, Buchwald, Ulrike K.
Publicado 2022

Establishing an Anal Cancer Screening Program in an Outpatient HIV Clinic: Referral Patterns and Patient Perceptions Survey

por Sowah, Leonard A., Schmalzle, Sarah A., Khambaty, Mariam, Buchwald, Ulrike K.
Publicado 2020

P06 The 15-valent pneumococcal conjugate vaccine (PCV) V114 induces cross-reactive antibodies against pneumococcal serotype 6C

por Shi, Yaru, Nolan, Katrina, Burton, Robert L, Murphy, Rocio, Banniettis, Natalie, Musey, Luwy, Buchwald, Ulrike
Publicado 2023

Implementation of an Infectious Disease Fellow-Managed Penicillin Allergy Skin Testing Service

por Heil, Emily L., Bork, Jacqueline T., Schmalzle, Sarah A., Kleinberg, Michael, Kewalramani, Anupama, Gilliam, Bruce L., Buchwald, Ulrike K.
Publicado 2016

Broad Adaptive Immune Responses to M. tuberculosis Antigens Precede TST Conversion in Tuberculosis Exposed Household Contacts in a TB-Endemic Setting

por Buchwald, Ulrike K., Adetifa, Ifedayo M. O., Bottomley, Christian, Owiafe, Patrick K., Donkor, Simon, Bojang, Adama L., Sutherland, Jayne S.
Publicado 2014

The 15-valent pneumococcal conjugate vaccine V114 induces cross-reactive antibodies against pneumococcal serotype 6C

por Shi, Yaru, Nolan, Katrina M., Burton, Robert L., Shekar, Tulin, Murphy, Rocio D., Banniettis, Natalie, Musey, Luwy, Buchwald, Ulrike K.
Publicado 2023

Active Tuberculosis Case Finding in Port-au-Prince, Haiti: Experiences, Results, and Implications for Tuberculosis Control Programs

por Delva, Guesly J., Francois, Ingrid, Claassen, Cassidy W., Dorestan, Darwin, Bastien, Barbara, Medina-Moreno, Sandra, Fort, Dumesle St., Redfield, Robert R., Buchwald, Ulrike K.
Publicado 2016

Safety, tolerability, and immunogenicity of V114, a 15-valent pneumococcal conjugate vaccine, administered concomitantly with influenza vaccine in healthy adults aged ≥50 years: a...

por Severance, Randall, Schwartz, Howard, Dagan, Ron, Connor, Laurie, Li, Jianing, Pedley, Alison, Hartzel, Jonathan, Sterling, Tina M., Nolan, Katrina M., Tamms, Gretchen M., Musey, Luwy K., Buchwald, Ulrike K.
Publicado 2021

P07 A Phase 3 randomized, double-blind, comparator-controlled study to evaluate safety, tolerability and immunogenicity of V114 pneumococcal vaccine in haematopoietic cell transpla...

por Wilck, Marissa, Cornely, Oliver A, Ljungman, Per, Cordonnier, Catherine, Velez, Juan Diego, Dagan, Ron, Richmond, Peter, Chen, Qiuxu, Daus, Caroline, Geddie, Kateasha, Sterling, Tina, Shekar, Tulin, Musey, Luwy, Buchwald, Ulrike K
Publicado 2023

1972. Safety and Immunogenicity of 15-Valent Pneumococcal Conjugate Vaccine (PCV-15) Compared with PCV-13 in Healthy Older Adults Previously Vaccinated With 23-Valent Pneumococcal...

por Buchwald, Ulrike, Peterson, James, Stacey, Helen, Julien, Katie, Sterling, Tina, Bruch, Melanie, Tamms, Gretchen, Li, Jianing, Pedley, Alison, Nolan, Katrina, Benner, Patrice, Abeygunawardana, Chitrananda, Winters, Michael, Kosinski, Michael, Stek, Jon, Musey, Luwy
Publicado 2018

Safety and Immunogenicity of V114 in Preterm Infants: A Pooled Analysis of Four Phase Three Studies

por Chapman, Timothy J., Patel, Shrita M., Flores, Sheryl A., Xu, Shengjie, Lupinacci, Robert, Shi, Yaru, Shekar, Tulin, Feemster, Kristen, Yi, Jumi, Tamms, Gretchen, Kaminski, Janusz, Bickham, Kara, Musey, Luwy, Buchwald, Ulrike K., Banniettis, Natalie
Publicado 2023

Safety and immunogenicity of V114, a 15-valent pneumococcal conjugate vaccine, in adults living with HIV

por Mohapi, Lerato, Pinedo, Yvett, Osiyemi, Olayemi, Supparatpinyo, Khuanchai, Ratanasuwan, Winai, Molina, Jean-Michel, Dagan, Ron, Tamms, Gretchen, Sterling, Tina, Zhang, Ying, Pedley, Alison, Hartzel, Jon, Kan, Yanqing, Hurtado, Kim, Musey, Luwy, Simon, Jakub K., Buchwald, Ulrike K.
Publicado 2022

Immunogenicity, Safety, and Tolerability of V114, a 15-Valent Pneumococcal Conjugate Vaccine, in Immunocompetent Adults Aged 18–49 Years With or Without Risk Factors for Pneumococc...

por Hammitt, Laura L, Quinn, Dean, Janczewska, Ewa, Pasquel, Francisco J, Tytus, Richard, Rajender Reddy, K, Abarca, Katia, Khaertynova, Ilsiyar M, Dagan, Ron, McCauley, Jennifer, Cheon, Kyeongmi, Pedley, Alison, Sterling, Tina, Tamms, Gretchen, Musey, Luwy, Buchwald, Ulrike K
Publicado 2021

1050. Phase 3 Trial to Evaluate the Safety, Tolerability, and Immunogenicity of V114 Followed by 23valent Pneumococcal Polysaccharide Vaccine 6 Months Later in At-risk Adults Aged...

por Hammitt, Laura, Quinn, Dean, Janczewska, Ewa, Pasquel, Francisco J, Tytus, Richard, Rajender Reddy, K, Abarca, Katia, Khaertynova, Ilsiyar M, Dagan, Ron, Dawson, Rachel, McCauley, Jennifer, Cheon, Kyeongmi, Pedley, Alison, Sterling, Tina, Tamms, Gretchen, Musey, Luwy, Buchwald, Ulrike K
Publicado 2021

Phase 3 trial to evaluate the safety, tolerability, and immunogenicity of V114, a 15-valent pneumococcal conjugate vaccine, followed by 23-valent pneumococcal polysaccharide vaccin...

por Hammitt, Laura L., Quinn, Dean, Janczewska, Ewa, Pasquel, Francisco J., Tytus, Richard, Reddy, K. Rajender, Abarca, Katia, Khaertynova, Ilsiyar M., Dagan, Ron, Dawson, Rachel, McCauley, Jennifer, Shekar, Tulin, Fu, Wei, Pedley, Alison, Sterling, Tina, Tamms, Gretchen, Musey, Luwy, Buchwald, Ulrike K.
Publicado 2023

Effectiveness, immunogenicity, and safety of the quadrivalent HPV vaccine in women and men aged 27–45 years

por Maldonado, Ivette, Plata, Manuel, Gonzalez, Mauricio, Correa, Alfonso, Nossa, Claudia, Giuliano, Anna R., Joura, Elmar A., Ferenczy, Alex, Ronnett, Brigitte M., Stoler, Mark H., Jin Zhou, Hao, Joshi, Amita, Das, Rituparna, Bautista, Oliver, Group, Thomas, Luxembourg, Alain, Saah, Alfred, Buchwald, Ulrike Kirsten
Publicado 2022

A Phase 3, Randomized, Double-Blind, Comparator-Controlled Study to Evaluate Safety, Tolerability, and Immunogenicity of V114, a 15-Valent Pneumococcal Conjugate Vaccine, in Alloge...

por Wilck, Marissa, Cornely, Oliver A, Cordonnier, Catherine, Velez, Juan Diego, Ljungman, Per, Maertens, Johan, Selleslag, Dominik, Mullane, Kathleen M, Nabhan, Samir, Chen, Qiuxu, Dagan, Ron, Richmond, Peter, Daus, Caroline, Geddie, Kateasha, Tamms, Gretchen, Sterling, Tina, Patel, Shrita M, Shekar, Tulin, Musey, Luwy, Buchwald, Ulrike K
Publicado 2023

Sequential administration of Prevnar 13™ and PNEUMOVAX™ 23 in healthy participants 50 years of age and older

por Buchwald, Ulrike K., Andrews, Charles P., Ervin, John, Peterson, James T., Tamms, Gretchen M., Krupa, David, Ajiboye, Patrick, Roalfe, Lucy, Krick, Andrea L., Sterling, Tina M., Wang, Meihua, Martin, Jason C., Stek, Jon E., Kohn, Melvin A., Folaranmi, Temitope, Abeygunawardana, Chitrananda, Hartzel, Jonathan, Musey, Luwy K.
Publicado 2021